Systems and methods for embolism prediction using embolus source and destination probabilities
Abstract
Systems and methods are disclosed for determining a patient risk assessment or treatment plan based on emboli dislodgement and destination. One method includes receiving a patient-specific anatomic model generated from patient-specific imaging of at least a portion of a patient's vasculature; determining or receiving a location of interest in the patient-specific anatomic model of the patient's vasculature; using a computing processor for calculating blood flow through the patient-specific anatomic model to determine blood flow characteristics through at least the portion of the patient's vasculature of the patient-specific anatomic model downstream from the location of interest; and using a computing processor for particle tracking through the simulated blood flow to determine a destination probability of an embolus originating from the location of interest in the patient-specific anatomic model, based on the determined blood flow characteristics.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A computer-implemented method of determining a patient risk assessment or treatment plan based on emboli dislodgement and destination, the method comprising:
receiving a patient-specific anatomic model generated from patient-specific imaging of at least a portion of a patient's vasculature; determining or receiving a location of interest in the patient-specific anatomic model of the patient's vasculature; using a computing processor for calculating blood flow through the patient-specific anatomic model to determine blood flow characteristics through at least the portion of the patient's vasculature of the patient-specific anatomic model downstream from the location of interest; and using a computing processor for particle tracking through the simulated blood flow to determine a destination probability of an embolus originating from the location of interest in the patient-specific anatomic model, based on the determined blood flow characteristics.
2 . The computer-implemented method of claim 1 , further comprising:
determining, in the patient's vasculature, a location of a plaque, a location meeting a predetermined criteria of pathology, or a location of possible vascular shedding; and determining or receiving the location of interest in the patient-specific anatomic model based on the determined location of plaque, determined location meeting the predetermined criteria of pathology, or the location of possible vascular shedding.
3 . The computer-implemented method of claim 1 , further comprising:
determining a target location in the patient's vasculature, wherein the destination probability is a probability that the embolus traveling through the patient's circulatory system reaches the target location, based on the determined blood flow characteristics.
4 . The computer-implemented method of claim 1 , further comprising:
determining a vulnerable location of embolism based on the determined destination probability.
5 . The computer-implemented method of claim 1 , further comprising:
determining an association between a target location in the patient-specific anatomic model, the destination probability, and the location of interest.
6 . The computer-implemented method of claim 5 , further comprising:
determining, for a second location of interest, a second destination probability of an embolus associated with the second location of interest; determining an association between the target location in the patient-specific anatomic model, the destination probability, and the second location of interest; comparing the association between the target location in the patient-specific anatomic model, the destination probability, and the location of interest, and the association between the target location in the patient-specific anatomic model, the destination probability, and the second location of interest; and determining generating a display or a treatment recommendation based on the comparison.
7 . The computer-implemented method of claim 1 , further comprising:
determining patient risk of a disease, based on the destination probability of the embolus, wherein the patient risk of the disease includes patient risk of a disease associated with a location in the patient's vasculature.
8 . The computer-implemented method of claim 7 , wherein the risk of disease includes a risk of embolism, cognitive impairment, stroke, transient ischemic attack, pulmonary embolism, renal embolism, or a combination thereof.
9 . A system for determining a patient risk assessment or treatment plan based on emboli dislodgement and destination, the system comprising:
a data storage device storing instructions for determining a patient risk assessment or treatment plan based on emboli dislodgement and destination; and a processor configured to execute the instructions to perform a method including:
receiving a patient-specific anatomic model generated from patient-specific imaging of at least a portion of a patient's vasculature;
determining or receiving a location of interest in the patient-specific anatomic model of the patient's vasculature;
using a computing processor for calculating blood flow through the patient-specific anatomic model to determine blood flow characteristics through at least the portion of the patient's vasculature of the patient-specific anatomic model downstream from the location of interest; and
using a computing processor for particle tracking through the simulated blood flow to determine a destination probability of an embolus originating from the location of interest in the patient-specific anatomic model, based on the determined blood flow characteristics.
10 . The system of claim 9 , wherein the system is further configured for:
determining, in the patient's vasculature, a location of a plaque, a location meeting a predetermined criteria of pathology, or a location of possible vascular shedding; and determining or receiving the location of interest in the patient-specific anatomic model based on the determined location of plaque, determined location meeting the predetermined criteria of pathology, or the location of possible vascular shedding.
11 . The system of claim 9 , wherein the system is further configured for:
determining a target location in the patient's vasculature, wherein the destination probability is a probability that the embolus traveling through the patient's circulatory system reaches the target location, based on the determined blood flow characteristics.
12 . The system of claim 9 , wherein the system is further configured for:
determining a vulnerable location of embolism based on the determined destination probability.
13 . The system of claim 9 , wherein the system is further configured for:
determining an association between a target location in the patient-specific anatomic model, the destination probability, and the location of interest.
14 . The system of claim 13 , wherein the system is further configured for:
determining, for a second location of interest, a second destination probability of an embolus associated with the second location of interest; determining an association between the target location in the patient-specific anatomic model, the destination probability, and the second location of interest; comparing the association between the target location in the patient-specific anatomic model, the destination probability, and the location of interest, and the association between the target location in the patient-specific anatomic model, the destination probability, and the second location of interest; and determining generating a display or a treatment recommendation based on the comparison.
15 . The system of claim 9 , wherein the system is further configured for:
determining patient risk of a disease, based on the destination probability of the embolus, wherein the patient risk of the disease includes patient risk of a disease associated with a location in the patient's vasculature.
16 . The system of claim 15 , wherein the risk of disease includes a risk of embolism, cognitive impairment, stroke, transient ischemic attack, pulmonary embolism, renal embolism, or a combination thereof.
17 . A non-transitory computer readable medium for use on a computer system containing computer-executable programming instructions for performing a method of determining a patient risk assessment or treatment plan based on emboli dislodgement and destination, the method comprising:
receiving a patient-specific anatomic model generated from patient-specific imaging of at least a portion of a patient's vasculature; determining or receiving a location of interest in the patient-specific anatomic model of the patient's vasculature; using a computing processor for calculating blood flow through the patient-specific anatomic model to determine blood flow characteristics through at least the portion of the patient's vasculature of the patient-specific anatomic model downstream from the location of interest; and using a computing processor for particle tracking through the simulated blood flow to determine a destination probability of an embolus originating from the location of interest in the patient-specific anatomic model, based on the determined blood flow characteristics.
18 . The non-transitory computer readable medium of claim 17 , the method further comprising:
determining, in the patient's vasculature, a location of a plaque, a location meeting a predetermined criteria of pathology, or a location of possible vascular shedding; and determining or receiving the location of interest in the patient-specific anatomic model based on the determined location of plaque, determined location meeting the predetermined criteria of pathology, or the location of possible vascular shedding.
19 . The non-transitory computer readable medium of claim 17 , the method further comprising:
determining a target location in the patient's vasculature, wherein the destination probability is a probability that the embolus traveling through the patient's circulatory system reaches the target location, based on the determined blood flow characteristics.
20 . The non-transitory computer readable medium of claim 19 , the method further comprising:
determining a vulnerable location of embolism based on the determined destination probability.Join the waitlist — get patent alerts
Track US2016203289A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.